The involvement of Interleukin-17 (IL-17) in inflammatory responses is particularly noteworthy, as recent studies have highlighted its impact on lipid metabolism, particularly in the context of obesity and metabolic disorders. This evidence concerns the gene IL17A and Other metabolic disease.